Loading...
NPI 1326059320 · West Caldwell, NJ · Geriatric Medicine (Internal Medicine) Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Pradip Shah is a geriatric medicine (internal medicine) physician provider located in West Caldwell, New Jersey. This profile covers 26 Medicare and 5 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Pradip Shah |
| Address | 459 Passaic Ave |
| City | West Caldwell |
| State | NJ |
| ZIP | 07006 |
| Taxonomy | Geriatric Medicine (Internal Medicine) Physician |
| NPI Enumerated | August 11, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $379.3K |
| Medicaid | $1.2K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
26 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99348 | The provider sees an established patient for a home or residence visit involving evaluation and management (E/M). The visit involves low medical decision making or the provider spends at least 30… | 1,010 | $60 | $55.6K |
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 340 | $130 | $42.9K |
| 99309 | The provider sees a patient for a subsequent nursing facility care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or the provider… | 400 | $90 | $36.5K |
| 99349 | The provider sees an established patient for a home or residence visit involving evaluation and management (E/M). The visit involves moderate medical decision making or the provider spends at least… | 460 | $80 | $35.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 470 | $70 | $34.5K |
| 90694 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is an inactivated, adjuvanted, preservative–free vaccine given as a 0.5 mL… | 420 | $80 | $32.1K |
| 99308 | The provider sees a patient for a subsequent nursing facility care visit involving evaluation and management (E/M). The visit involves a low level of medical decision making and/or the provider… | 360 | $60 | $23K |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 360 | $50 | $16.4K |
| 99457 | The provider manages treatment using data from remote physiologic monitoring. The service requires at least one real–time interactive communication with the patient or caregiver during the month and… | 390 | $40 | $15.9K |
| 99454 | The provider supplies one or more devices for remote physiologic monitoring that occurs for 16 to 30 days in a 30–day period. | 330 | $40 | $14.6K |
Showing 1–10 of 26
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 26 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
26 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 99309 | 489 | 1,400 | 210 | $80 | $37.5K |
| 99308 | 576 | 1,430 | 230 | $60 | $29.5K |
| 99214 | 2,199 | 13,640 | 130 | $90 | $23.6K |
| 99349 | 89 | 580 | 100 | $90 | $20.7K |
| 99350 | 136 | 290 | 80 | $120 | $18.6K |
| 99310 | 486 | 570 | 70 | $120 | $17.8K |
| 91322 | 720 | 780 | 80 | $140 | $16.8K |
| 91320 | 74 | 780 | 70 | $130 | $16.5K |
| 99306 | 442 | 850 | 50 | $150 | $13.3K |
| 99213 | 6,303 | 14,090 | 100 | $70 | $13.1K |
Showing 1–10 of 26
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
5 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 40 | $10 | $520 |
| 90694 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is an inactivated, adjuvanted, preservative–free vaccine given as a 0.5 mL… | 70 | $1 | $200 |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 40 | $1 | $180 |
| 90653 | This code represents an inactivated influenza vaccine product that contains subunits of the virus and an adjuvant to enhance the immune response. The vaccine is administered via separately reportable… | 20 | $10 | $150 |
| G0008 | Administration of influenza virus vaccine | 90 | $1 | $90 |
How this provider's Medicaid billing volume and revenue compare to other New Jersey providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New Jersey median
5 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 17 | 60 | 30 | $20 | $1K |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 33 | 90 | 30 | $10 | $820 |
| G0008 | Administration of influenza virus vaccine | 312 | 870 | 50 | $1 | $550 |
| 90694 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is an inactivated, adjuvanted, preservative–free vaccine given as a 0.5 mL… | 35 | 130 | 40 | $10 | $500 |
| 90653 | This code represents an inactivated influenza vaccine product that contains subunits of the virus and an adjuvant to enhance the immune response. The vaccine is administered via separately reportable… | 36 | 80 | 20 | $10 | $370 |
Other providers in the same ZIP code as Pradip Shah, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Gohewec Healthcare Providers | NJ | Home Health Agency | $0 | $13.3M |
| Edward Kosoy | NJ | Family Medicine Physician | $1.8M | $500 |
| New Jersey Cvs Pharmacy LLC | NJ | Pharmacy | $240.9K | $0 |
| David Chen | NJ | Ophthalmology Physician | $139.1K | $0 |
| Giovanni Campanile | NJ | Cardiovascular Disease Physician | $78.3K | $0 |
| Yael Gottlieb | NJ | Physician Assistant | $72.3K | $0 |
| Caldwell Pharmacy | NJ | Community/Retail Pharmacy | $45.9K | $0 |
| John Secoy | NJ | Pain Medicine (Anesthesiology) Physician | $9.4K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.